Aberdeen Group
PRAX icon

Aberdeen Group’s Praxis Precision Medicines PRAX Stock Holding History

Aberdeen Group’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.7M Sell
166,399
-6,085
-4% -$1.93M 0.08% 208
2026
Q1 		$55.6M Buy
172,484
+37,492
+28% +$11.6M 0.09% 190
2025
Q4 		$39.8M Buy
+134,992
New +$25.1M 0.06% 258
2025
Q3 		– Sell
-214,056
Closed -$9M – 975
2025
Q2 		$9M Buy
214,056
+126,153
+144% +$4.8M 0.02% 620
2025
Q1 		$3.33M Buy
87,903
+82,904
+1,658% +$5.18M 0.01% 716
2024
Q4 		$385K Hold
4,999
– – ﹤0.01% 883
2024
Q3 		$288K Hold
4,999
– – ﹤0.01% 876
2024
Q2 		$207K Hold
4,999
– – ﹤0.01% 926
2024
Q1 		$305K Buy
+4,999
New +$224K ﹤0.01% 900

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Aberdeen Group's PRAX Position: Q2 2026 in Review

Aberdeen Group reduced its Praxis Precision Medicines (PRAX) stake by 3.5% in Q2 2026, selling an estimated $1.93M and leaving 166,399 shares worth $55.7M. The position accounts for 0.08% of the portfolio, ranked #208.

Aberdeen Group first reported a position in PRAX in Q1 2024 and has held it in 9 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Aberdeen Group held 166,399 shares of Praxis Precision Medicines worth $55.7M as of Q2 2026.
  • Aberdeen Group sold 6,085 Praxis Precision Medicines shares in Q2 2026, an estimated $1.93M.
  • Praxis Precision Medicines made up 0.08% of Aberdeen Group's portfolio in Q2 2026, its #208 holding.
  • Aberdeen Group first reported a position in Praxis Precision Medicines in Q1 2024 and has held it in 9 quarters since.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.